Zobrazit v EDS

Tau Pathology Drives Disease‐Associated Astrocyte Reactivity in Salt‐Induced Neurodegeneration.

Uloženo v:
Podrobná bibliografie
Název: Tau Pathology Drives Disease‐Associated Astrocyte Reactivity in Salt‐Induced Neurodegeneration.
Autoři: Rui, Tong‐Yu, Huang, He‐Zhou, Zheng, Kai, Fan, Hong‐Wei, Zhang, Juan, Guo, Zi‐Yuan, Man, Heng‐Ye, Brazhe, Nadezhda, Semyanov, Alexey, Lu, You‐Ming, Liu, Dan, Zhu, Ling‐Qiang
Zdroj: Advanced Science; 3/20/2025, Vol. 12 Issue 11, p1-19, 19p
Témata: DISEASE risk factors, HIGH-salt diet, ALZHEIMER'S disease, TAU proteins, COGNITION disorders
Abstrakt: Dietary high salt intake is increasingly recognized as a risk factor for cognitive decline and dementia, including Alzheimer's disease (AD). Recent studies have identified a population of disease‐associated astrocytes (DAA)‐like astrocytes closely linked to amyloid deposition and tau pathology in an AD mouse model. However, the presence and role of these astrocytes in high‐salt diet (HSD) models remain unexplored. In this study, it is demonstrated that HSD significantly induces enhanced reactivity of DAA‐like astrocytes in the hippocampal CA3 region of mice, with this reactivity being critically dependent on neuronal tau pathology. Neuronal tau pathology activates adenosine A1R signaling, exacerbating tau pathology by inhibiting the Cers1 pathway, which sustains astrocyte reactivity. Additionally, neurons burdened with tau pathology promote astrocyte reactivity via releasing Proteins Associated with Promoting DAA‐like Astrocyte Reactivity (PAPD), with Lcn2 playing a pivotal role. Knockout of Lcn2 or its receptor 24p3R significantly mitigates HSD‐induced DAA reactivity and neuroinflammation. These findings suggest a vicious cycle between tau pathology and A1R signaling, driving DAA‐like astrocyte reactivity. Targeting the Tau‐A1R axis may provide a novel therapeutic strategy for reducing HSD‐induced neuroinflammation and cognitive deficits. [ABSTRACT FROM AUTHOR]
Copyright of Advanced Science is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Databáze: Complementary Index
Popis
Abstrakt:Dietary high salt intake is increasingly recognized as a risk factor for cognitive decline and dementia, including Alzheimer's disease (AD). Recent studies have identified a population of disease‐associated astrocytes (DAA)‐like astrocytes closely linked to amyloid deposition and tau pathology in an AD mouse model. However, the presence and role of these astrocytes in high‐salt diet (HSD) models remain unexplored. In this study, it is demonstrated that HSD significantly induces enhanced reactivity of DAA‐like astrocytes in the hippocampal CA3 region of mice, with this reactivity being critically dependent on neuronal tau pathology. Neuronal tau pathology activates adenosine A1R signaling, exacerbating tau pathology by inhibiting the Cers1 pathway, which sustains astrocyte reactivity. Additionally, neurons burdened with tau pathology promote astrocyte reactivity via releasing Proteins Associated with Promoting DAA‐like Astrocyte Reactivity (PAPD), with Lcn2 playing a pivotal role. Knockout of Lcn2 or its receptor 24p3R significantly mitigates HSD‐induced DAA reactivity and neuroinflammation. These findings suggest a vicious cycle between tau pathology and A1R signaling, driving DAA‐like astrocyte reactivity. Targeting the Tau‐A1R axis may provide a novel therapeutic strategy for reducing HSD‐induced neuroinflammation and cognitive deficits. [ABSTRACT FROM AUTHOR]
ISSN:21983844
DOI:10.1002/advs.202410799